Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
4,503 people get MON articles and Market Currents by email alert.
Get email alerts on MON »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
PR Newswire (Fri, 10:00AM)
-
-
-
-
PR Newswire (May 1, 2013)
-
-
-
-
-
PR Newswire (Apr 23, 2013)
-
Monsanto Co. Dividend Stock AnalysisDividends4Life • Thu, Apr 18 -
PR Newswire (Apr 16, 2013)
-
-
PR Newswire (Apr 15, 2013)
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
Monsanto Co. Dividend Stock AnalysisDividends4Life • Thu, Apr 18
-
-
-
-
-
-
-
-
-
-
-
-
Earnings Analysis: MonsantoCapitalCube • Fri, Oct 5, 2012 -
-
-
-
-
-
Monsanto Management Discusses Q3 2012 Results - Earnings Call TranscriptWed, Jun 27, 2012
-
Monsanto's CEO Discusses Q2 2012 Results - Earnings Call TranscriptWed, Apr 4, 2012
-
Monsanto's CEO Discusses Q1 2012 Results - Earnings Call TranscriptThu, Jan 5, 2012
-
Monsanto's CEO Discusses Q4 2011 Results - Earnings Call TranscriptWed, Oct 5, 2011
-
Monsanto's CEO Discusses Q3 2011 Results - Earnings Call TranscriptWed, Jun 29, 2011
-
Monsanto's CEO Discusses Q2 2011 Results - Earnings Call TranscriptWed, Apr 6, 2011 • 1 Comment
-
Monsanto CEO Discusses F1Q11 Results - Earnings Call TranscriptThu, Jan 6, 2011
-
Monsanto Company F3Q10 (Qtr End 05/31/2010) Earnings Call TranscriptWed, Jun 30, 2010
-
Monsanto Company F2Q10 (Qtr End 02/28/2010) Earnings Call TranscriptWed, Apr 7, 2010
-
Monsanto Company F1Q10 (Qtr End 11/30/09) Earnings Call TranscriptWed, Jan 6, 2010
-
Monsanto Company F4Q09 (Qtr End 08/31/09) Earnings Call TranscriptWed, Oct 7, 2009
-
Monsanto Company F3Q09 (Qtr End 5/31/09) Earnings Call TranscriptThu, Jul 30, 2009
-
Monsanto Company F2Q09 (Qtr End 2/28/09) Earnings Call TranscriptThu, Apr 2, 2009
-
Monsanto Company F1Q09 (Qtr End 11/30/08) Earnings Call TranscriptWed, Jan 7, 2009
-
Monsanto Company F4Q08 (Qtr End 08/31/08) Earnings Call TranscriptWed, Oct 8, 2008
-
Monsanto Company F3Q08 (Qtr End 5/31/08) Earnings Call TranscriptWed, Jun 25, 2008
-
Monsanto Company F2Q08 (Qtr End 02/29/08) Earnings Call TranscriptWed, Apr 2, 2008
-
PR Newswire (Fri, 10:00AM)
-
at CNBC.com (May 13, 2013)
-
at CNBC.com (May 13, 2013)
-
at CNBC.com (May 13, 2013)
-
at Fox Business (May 13, 2013)
-
at CNBC.com (May 8, 2013)
-
PR Newswire (May 1, 2013)
-
PR Newswire (Apr 23, 2013)
-
at Fox Business (Apr 23, 2013)
-
PR Newswire (Apr 16, 2013)
-
PR Newswire (Apr 15, 2013)
-
at Fox Business (Apr 8, 2013)
-
at CNBC.com (Apr 3, 2013)
-
at MarketWatch.com (Apr 3, 2013)
-
at MarketWatch.com (Apr 3, 2013)
-
at Fox Business (Apr 3, 2013)
MON vs. ETF Alternatives
Company Description
Monsanto Company, along with its subsidiaries, is a leading global provider of agricultural products for farmers. Our seeds, biotechnology trait products, and herbicides provide farmers with solutions that improve productivity, reduce the costs of farming, and produce better foods for consumers... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Sunday, November 18, 2012, 3:39 AM The DOJ has ended an antitrust investigation into the U.S. seed industry without filing charges. Justice had requested information from Monsanto (MON) about its business practices regarding to its Roundup Ready soybean, which is designed to withstand the application of the herbicide glyphosate. DuPont (DD) also received a demand for information but doesn't believe the probe was aimed at its behavior. Comment! [Commodities]
- Monday, November 5, 2012, 11:31 AM Monsanto (MON +1.3%) is upgraded to Buy with a new $100 target price at Monness Crespi, as continually increasing glyphosate prices are leading to greater EPS upside in 2013. The firm sees MON benefiting from these higher prices, both in its branded Roundup products as well as in its generic glyphosate, and raises estimates to well above consensus. 1 Comment [Commodities, Quick Ideas]
- Tuesday, October 23, 2012, 2:05 PM The slide in DuPont (DD -9%) shares wipes away all their 2012 gains following the weak Q3 earnings report. But DD says it remains on track to achieve its full-year 2012 productivity targets for both fixed costs and working capital, and it is "taking the necessary steps" to move long-term into higher growth, higher margin businesses such as agriculture, nutrition and biotech. Also: DOW -3.1%, MON -1.8%. 1 Comment [Commodities, On the Move]
- Monday, October 22, 2012, 5:13 PM The French government decides against seeking a ban on EU imports of a type of Monsanto's (MON) genetically modified corn after the country's food safety agency ruled that a study linking the crop to cancers in rats was flawed and inconclusive. 5 Comments [Commodities, On the Move]
- Wednesday, October 17, 2012, 12:10 PM Monsanto (MON -1.6%) suspends soybean royalty collections in Brazil while it appeals a state court ruling on intellectual property rights siding with a group of growers that a patent on first-generation Roundup Ready soybeans had expired. MON expects appellate courts to decide whether collections can resume over the next several weeks, prior to the start of an actual trial. Comment! [Commodities, On the Move]
- Friday, October 5, 2012, 5:07 PM The Supreme Court agrees to hear an Indiana farmer's appeal that challenges the patent rights of Monsanto's (MON) Roundup Ready seeds. MON, whose genetically modified seeds produce crops resistant to herbicide, has required farmers to use the patented seeds only for a single crop and not save the second-generation seeds from the harvest. 3 Comments [Commodities]
- Wednesday, October 3, 2012, 8:49 AM More on Monsanto's (MON) FQ4 results: In addition to missing its EPS and revenue numbers, MON issues downside guidance for FY 2013, seeing EPS of $4.18-$4.32 vs. $4.37 analyst consensus. For FY 2012, Seeds and Genomics sales were $9.8B, a 14% increase Y/Y; FQ4 sales in the segment were $1.2B, 10% lower Y/Y. MON -3.1% premarket. 1 Comment [Commodities, On the Move]
- Wednesday, October 3, 2012, 8:08 AM Monsanto (MON): FQ4 EPS of -$0.44 misses by $0.01. Revenue of $2.18B misses by $70M. Shares -3.7% premarket. (PR) Comment! [Earnings, On the Move]
- Wednesday, October 3, 2012, 12:05 AM Notable earnings before Wednesday’s open: FDO, MON, RPM Comment! [Earnings]
- Tuesday, October 2, 2012, 5:30 PM Notable earnings before Wednesday’s open: FDO, MON, RPM Comment! [Earnings]
- Friday, September 28, 2012, 11:13 AM Monsanto's (MON -0.2%) genetically engineered NK603 corn should be banned in South Africa because it is hazardous to the health, according to the African Centre for Biosafety, following a French study that found the product caused cancer in rats. White corn is a staple food in South Africa, where genetically modified plants accounted for 80% of the harvest last year. 2 Comments [Commodities, Global & FX]
- Thursday, September 27, 2012, 9:07 AM Monsanto (MON) +1.5% premarket after Wells Fargo upgrades shares to Outperform with a $104-$106 target price range, up from $82-$84: "With Chinese glyphosate challenges seemingly well behind them, we expect MON to benefit from higher seed pricing (up 5-10% in FY2013) and penetration in Latin America (through the introduction of double and triple stacked traits)." Comment! [Commodities, Quick Ideas, On the Move]
- Tuesday, September 25, 2012, 11:38 AM Russia suspends the import and sales of Monsanto's (MON) genetically modified NK603 corn until the country gets further information on the safety of the products. Scientists at Russia’s Institute of Nutrition are asked to review the French study which raised questions about the long-term effect of MON’s NK 603 corn on rats. Comment! [Commodities, Consumer, Global & FX]
- Thursday, September 20, 2012, 9:34 AM Austrian agriculture minister Niki Berlakovich calls on the European Commission to review its approval process for GM food after a controversial two-year French study linked Monsanto's (MON) corn to increased cancer in rats. France's government has asked its health regulator to analyze the findings, although some scientists questioned the study's methodology. 1 Comment
- Wednesday, September 19, 2012, 3:39 PM "Monsanto’s (MON +2.8%) doing a lot of things right," OptionMonster’s Jon Najarian tells CNBC, adding the stock's two-year rise could continue as demand grows for MON’s genetically engineered, drought-resistant seeds. Shares are strong today, as investors focus on Goldman's upgrade rather than a study that said rats developed tumors after being exposed to certain MON products. 3 Comments [Commodities, Quick Ideas, On the Move]
- Wednesday, September 19, 2012, 7:51 AM Rats fed with Monsanto's (MON +1.7%) GM corn in a French study, or exposed to its Roundup weedkiller, suffered mammary tumors, and severe liver and kidney damage. Around 50% of males and 70% of females died prematurely vs. 30% and 20% in the control group. However, the lead researcher has a record as a critic of the GM industry, so other experts may be wary of drawing quick conclusions. 9 Comments
-
Jim Van Meerten
$MON - 100% Barchart technical buy signals - 4 new hgihs and up 3.25% in the last month - Relative Strength Index 67.98% - View all 0 replies
-
Option Millionaires
$XOM, $MON, $XLB, $XLE Sectors and stocks showing strength as inflation expectations rise to new highs. http://bit.ly/QSqxge - View all 0 replies
-
sarfralogy
Monsanto (MON) provides royalty-free access to agricultural biotechnology, but at what cost? http://bit.ly/RT9DL0 - View all 0 replies
-
The Oxen Group
4 Stocks To Trade, Weekly Outlook, bullish trades on $DIS $RIG, bearish trades on $DLTR $MON http://stks.co/cCij - View all 0 replies
-
- View all 27 replies
-
slimmbrimm: Good Doc, same as what i heard, men in black roll up to your farm, very strong armed tactics have kept most around me from using their seeds -
Dr. Kris: Jason: Thanks for the link. It appears Monsanto's Roundup has created a new use for its Agent Orange via immune superweeds. Mind boggling.
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Ryan Mallory
Fuinhaz $SPY morning update for July 23, 2012 http://bit.ly/Obv2iU SPY OREX PETM GMCR MON - View all 0 replies
-
The Oxen Group
MON has been outperforming market as of late and has taken some key MA's. We recommend an 80/77.50 Bull Put Spread. http://stks.co/h259 - View all 0 replies
LATEST REPLIES